Healthcare Industry News: Dover
News Release - March 12, 2008
TissueLink Medical Changes Name to Salient Surgical Technologies
Dover, N.H.--(HSMN NewsFeed)--TissueLink Medical, Inc., a privately held medical device company, announced today that the Company has changed its name to Salient Surgical Technologies, Inc. The name change is effective today.Joe Army, President & CEO of the Company commented: “The name change ensures that our Company will no longer be mistaken for a biologics or tissue bank company. The new name - Salient Surgical Technologies – reflects our focus on delivering surgical products that provide improved clinical and economic value to customers.”
About Salient Surgical Technologies, Inc.
Salient Surgical Technologies is a medical technology company that develops and markets surgical products based on its proprietary Transcollation™ technology for the sealing of blood vessels and other collagen-based structures. Transcollation technology integrates saline and radiofrequency energy via saline-induced liquid electrodes that deliver thermal energy to selected tissues and bone. Current applications for the Company's Transcollation technology include reducing blood loss during and after orthopedic hip and knee reconstructions, multi-level spinal fusions and surgical oncology. To date, Transcollation technology has been used in over 165,000 surgical procedures.
For more information on Salient Surgical Technologies, visit the Company’s website at www.salientsurgical.com.
Source: TissueLink Medical
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!